CatalystCorporate
J&J raised its 2026 sales outlook to 6.7%-7.1% growth with a $100.7B midpoint. Lifting guidance on a base that big is a demand signal, not a rounding error. Pharma's growth question gets a better answ
Johnson & Johnson raised 2026 sales outlook to 6.7%-7.1% with $100.7B midpoint revenue.
What changed
Johnson & Johnson raised 2026 sales outlook to 6.7%-7.1% with $100.7B midpoint revenue.
Why it matters
Johnson & Johnson raised 2026 sales outlook to 6.7%-7.1% with $100.7B midpoint revenue. — impact context not separately stored; see What changed.
← Dashboard
Oct 13, 2026 09:06 PM ET